3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Prostatic Neoplasms
3
Neoplasms
3
Non-Muscle Invasive Bladder Neoplasms
2
Lymphoma, B-Cell
2
Carcinoma, Transitional Cell
2
Carcinoma
2
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Synovial
1
Pancreatic Neoplasms
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Histologic Type
1
Neoplasm, Residual
1
Lung Neoplasms
1
Liposarcoma, Myxoid
1
Leukemia, Myeloid, Acute
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Adenocarcinoma
1
Interventions
Vincristine
9
Cyclophosphamide
8
Magnetic Resonance Spectroscopy
7
X-Rays
6
Temozolomide
6
Specimen Handling
6
Phantoms, Imaging
6
Irinotecan
6
Biopsy
5
Radiotherapy
4
Radiation
4
Nuclear Medicine Department, Hospital
4
Dactinomycin
4
fludarabine
3
Vinorelbine
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
ensartinib
2
Proton Therapy
2
LY3023414
2
Ifosfamide
2
Filgrastim
2
Etoposide
2
Doxorubicin
2
Dexrazoxane
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
ALT-803
×
90 days
×
Clear all
No trials found.